Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 09-2023 | |
| Operating Expenses | 1,506 | 0 | 1,157 | 0 | 176 |
| Operating Income | -1,506 | N/A | -1,157 | N/A | -176 |
| Interest Expense | 3 | 0 | 4 | 0 | 28 |
| Other Income | 756 | 0 | 1,302 | 0 | -106 |
| Pre-tax Income | -753 | 0 | 142 | 0 | -310 |
| Net Income Continuous | -753 | N/A | 142 | N/A | -310 |
| Net Income | $-753 | $N/A | $142 | $N/A | $-310 |
| EPS Basic Total Ops | -3.19 | N/A | 25.44 | N/A | N/A |
| EPS Basic Continuous Ops | -3.18 | N/A | 25.47 | N/A | N/A |
| EPS Diluted Total Ops | -3.19 | N/A | 25.44 | N/A | N/A |
| EPS Diluted Continuous Ops | -3.18 | N/A | 25.46 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | 25.34 | -0.02 | -0.02 |
| EBITDA(a) | $-1,506 | $N/A | $-1,157 | $N/A | $-176 |